Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management

Key Takeaway: Stevanato Group has launched Deora™, a pen injector designed for subcutaneous delivery. This device targets diabetes and weight management, aiming to enhance patient experience. The introduction of Deora™ reflects the company's commitment to innovative healthcare solutions.